Hi Andrey,
Thanks for the continuous updates, it's much appreciated!
We were running the latest version of isoquant (3.11.1) and you have included a default of 1 million coverage for chrM, which solves a lot of the processing time issues that were present in the older versions.
However, we now run in to the issue that typically the % of MT genes is used in downstream scRNAseq analyses as a quality control. How I understand it, with the current implementation the %MT is artificially downsampled and thus not really reflective anymore of a cell quality.
Do you have any possible solution/guidelines for this? Is it for instance possible to perform isoform predicition (which if I understand correctly is the problematic step on small high coverage regions) on a subset of chromosomes (for example, human chr1-22XY) but keep the gene-level and/or (known) transcript-level quantification on all chromosomes?
Many thanks,
Luuk
Hi Andrey,
Thanks for the continuous updates, it's much appreciated!
We were running the latest version of isoquant (3.11.1) and you have included a default of 1 million coverage for chrM, which solves a lot of the processing time issues that were present in the older versions.
However, we now run in to the issue that typically the % of MT genes is used in downstream scRNAseq analyses as a quality control. How I understand it, with the current implementation the %MT is artificially downsampled and thus not really reflective anymore of a cell quality.
Do you have any possible solution/guidelines for this? Is it for instance possible to perform isoform predicition (which if I understand correctly is the problematic step on small high coverage regions) on a subset of chromosomes (for example, human chr1-22XY) but keep the gene-level and/or (known) transcript-level quantification on all chromosomes?
Many thanks,
Luuk